NCT01394055View on ClinicalTrials.gov

Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

December 31, 2012

Conditions
Diabetes Mellitus Type 1 and 2Diabetes Mellitus ComplicationsGastroparesisGastrointestinal Motility Disorder
Interventions
DRUG

RM-131

100 μg subcutaneously once

DRUG

Placebo

Matching placebo volume subcutaneously once

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors
All Listed Sponsors
lead

Motus Therapeutics, Inc.

INDUSTRY